GGrantIndex
← Leaderboards

John H Elder

Scripps Research Institute

Google Scholar ↗PubMed ↗ORCID ↗
$17,394,458
Attributed
$17,394,458
Total exposure
21
Grants
16
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.4M · FY2005–16
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16

Funding mix

By agency

NIH$17,394,458 · 21

By mechanism

R01$10,919,043 · 4
T32$2,435,021 · 1
P50$2,124,271 · 2
R21$1,427,870 · 3
P01$429,586 · 3
P41$58,667 · 7

Top collaborators

No co-investigators on record.

Most similar at Scripps Research Institute

Same institution · by research overlap

Others in their field

Top investigators on “Feline Immunodeficiency Virus”

Research focus

Feline Immunodeficiency VirusReceptor BindingInfectionVirusBinding (Molecular Function)GrantCellsViralTissue /Cell CultureMutantBaseAntibodiesFelis CatusMapsFamily FelidaeCxcr4 GeneVirus DiseasesReceptorProteinsMolecularAntiviral AgentsPeptidesCatsResearch Personnel

Grant awards (65)

Project 2$451,378
P50 · FY2016 · GM · contact PI
Potential Protein Coding Regions in FIV Negative Strand RNA$240,625
R21 · FY2016 · AI · contact PI
Molecular Characterization of FIV$443,441
R01 · FY2015 · AI · contact PI
Project 2$362,209
P50 · FY2015 · GM · contact PI
Potential Protein Coding Regions in FIV Negative Strand RNA$284,250
R21 · FY2015 · AI · contact PI
Molecular Characterization of FIV$443,150
R01 · FY2014 · AI · contact PI
Project 2$331,037
P50 · FY2014 · GM · contact PI
Humoral response to viral and self-antigens in HIV infection$236,875
R21 · FY2014 · AI · contact PI
Molecular Characterization of FIV$416,421
R01 · FY2013 · AI · contact PI
Project 2$322,222
P50 · FY2013 · GM · contact PI
Humoral response to viral and self-antigens in HIV infection$267,195
R21 · FY2013 · AI · contact PI
Molecular Characterization of FIV$442,625
R01 · FY2012 · AI · contact PI
Project 2$320,272
P50 · FY2012 · GM · contact PI
Molecular Characterization of FIV$464,625
R01 · FY2011 · AI · contact PI
Structural basis for drug resistance in HIV and FIV PRs$474,750
R01 · FY2010 · AI · contact PI
Molecular Analysis of FIV$368,081
R01 · FY2010 · AI · contact PI
Virology of the Central Nervous System$186,137
T32 · FY2010 · NS · contact PI
MOLECULAR ANALYSIS OF FIV$2,425
P41 · FY2010 · RR · contact PI
Structural basis for drug resistance in HIV and FIV PRs$474,750
R01 · FY2009 · AI · contact PI
Molecular Analysis of FIV$371,799
R01 · FY2009 · AI · contact PI
Virology of the Central Nervous System$217,910
T32 · FY2009 · NS · contact PI
STRUCTURAL MAPPING OF CD134 BINDING RECEPTOR FOR BINDING OF FIV$24,282
P41 · FY2009 · RR · contact PI
QUESTION OR TRAINING REQUEST FOR THE YEAST RESOURCE CENTER$4,839
P41 · FY2009 · RR · contact PI
MOLECULAR ANALYSIS OF FIV$3,332
P41 · FY2009 · RR · contact PI
Molecular Analysis of FIV$371,799
R01 · FY2008 · AI · contact PI
Molecular Analysis of a Highly Pathogenic FIV$319,953
R01 · FY2008 · AI · contact PI
Protein Production, Analysis and Assay Development$315,749
P01 · FY2008 · GM · contact PI
Virology of the Central Nervous System$223,210
T32 · FY2008 · NS · contact PI
STRUCTURAL MAPPING OF CD134 BINDING RECEPTOR FOR BINDING OF FIV$3,368
P41 · FY2008 · RR · contact PI
Molecular Analysis of FIV$372,800
R01 · FY2007 · AI · contact PI
Molecular Analysis of a Highly Pathogenic FIV$322,566
R01 · FY2007 · AI · contact PI
Virology of the Central Nervous System$201,079
T32 · FY2007 · NS · contact PI
STRUCTURAL MAPPING OF CD134 BINDING RECEPTOR FOR BINDING OF FIV$7,638
P41 · FY2007 · RR · contact PI
Molecular Analysis of a Highly Pathogenic FIV$332,201
R01 · FY2006 · AI · contact PI
Substrate/Inhibitor Specificity of FIV and HIV PRs$271,272
R01 · FY2006 · AI · contact PI
Virology of the Central Nervous System$144,981
T32 · FY2006 · NS · contact PI
STRUCTURAL MAPPING OF CD134 BINDING RECEPTOR FOR BINDING OF FIV$12,783
P41 · FY2006 · RR · contact PI
Molecular Analysis of FIV$398,925
R01 · FY2005 · AI
Molecular Analysis of a Highly Pathogenic FIV$361,670
R01 · FY2005 · AI
Virology of the Central Nervous System$313,839
T32 · FY2005 · NS
Substrate/Inhibitor Specificity of FIV and HIV PRs$277,800
R01 · FY2005 · AI
Molecular Analysis of FIV$398,925
R01 · FY2004 · AI
Virology of the Central Nervous System$315,900
T32 · FY2004 · NS
Substrate/Inhibitor Specificity of FIV and HIV PRs$277,800
R01 · FY2004 · AI
Molecular Analysis of FIV$398,925
R01 · FY2003 · AI
Virology of the Central Nervous System$311,675
T32 · FY2003 · NS
Substrate/Inhibitor Specificity of FIV and HIV PRs$277,800
R01 · FY2003 · AI
Molecular Analysis of FIV$398,925
R01 · FY2002 · AI
MOLECULAR ANALYSIS OF A HIGHLY PATHOGENIC FIV$331,165
R01 · FY2002 · AI
Substrate/Inhibitor Specificity of FIV and HIV PRs$277,800
R01 · FY2002 · AI
Virology of the Central Nervous System$272,924
T32 · FY2002 · NS
CORE--DEVELOPMENT$0
P30 · FY2002 · MH
Core--Protein expression, synthesis and analysis$0
P01 · FY2002 · GM
CAT/MOUSE MODELS TO EVALUATE PR-TARGETED ANTIVIRALS$398,925
R21 · FY2001 · AI
Molecular Analysis of FIV$378,979
R01 · FY2001 · AI
MOLECULAR ANALYSIS OF A HIGHLY PATHOGENIC FIV$331,165
R01 · FY2001 · AI
Virology of the Central Nervous System$247,366
T32 · FY2001 · NS
CORE--DEVELOPMENT$0
P30 · FY2001 · MH
MOLECULAR VIROLOGY OF THE FELINE IMMUNODEFICIENCY VIRUS PROTEASE$0
P01 · FY2001 · GM
MOLECULAR CHARACTERIZATION OF FIV$358,066
R01 · FY2000 · AI
MOLECULAR ANALYSIS OF A HIGHLY PATHOGENIC FIV$350,490
R01 · FY2000 · AI
FELINE IMMUNODEFICIENCY VIRUS INFECTION AS A MODEL FOR CNS INFECTION$337,153
P50 · FY2000 · MH
DEFINING SUBSTRATE AND INHIBITOR SPECIFICITIES OF FIV PR$210,375
R01 · FY2000 · AI
MOLECULAR VIROLOGY OF THE FELINE IMMUNODEFICIENCY VIRUS PROTEASE$113,837
P01 · FY2000 · GM
CORE--DEVELOPMENT$0
P30 · FY2000 · MH